Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Psychedelics Industry Ponders How to Go Mainstream: The Dose

July 25, 2022, 11:00 AM

Welcome to the latest edition of The Dose. This week, Kristen V. Brown from the health team fills in for Tiffany. She digs into the debate over how to bring psychedelic drugs to the masses.

Powerful substances face a vexing debate

The broad category of drugs we have come to call psychedelics are among the most buzzed-about in a very long time. Study results have been breathtaking, showing total symptom alleviation for conditions including post-traumatic stress disorder and depression in huge percentages of patients previously resistant to treatment. Equally astounding are the diverse conditions that these drugs might treat, from addiction and anorexia to migraines. ...